IDO1 and central nervous system cancer: Glioma cells can generate a great amount of indolamine 2,3-dioxygenase (IDO) to both inhibit T cell activity and promote the recruitment of regulatory T cells (Treg) through depletion of tryptophan from the microenvironment (39).